Assetmark, Inc Moderna, Inc. Transaction History

Assetmark, Inc

$36.2 Billion
Q1 2025

A detailed history of Assetmark, Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 546 shares of MRNA stock, worth $15,113. This represents 0.0% of its overall portfolio holdings.

Number of Shares

546

Previous 367 48.77%

Holding current value

$15,113

Previous $15,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	BUY	$28.35 - $47.53 $5,074 - $8,507	179 Added 48.77%	546 $15,000
Q4 2024 Feb 06, 2025	BUY	$36.85 - $63.93 $5,011 - $8,694	136 Added 58.87%	367 $15,000
Q3 2024 Nov 01, 2024	SELL	$63.64 - $125.14 $2.92 Million - $5.75 Million	-45,938 Reduced 99.5%	231 $15,000
Q2 2024 Aug 13, 2024	SELL	$101.21 - $166.61 $351,097 - $577,970	-3,469 Reduced 6.99%	46,169 $5.48 Million
Q1 2024 May 06, 2024	SELL	$85.37 - $115.44 $48.6 Million - $65.7 Million	-569,514 Reduced 91.98%	49,638 $5.29 Million
Q4 2023 Feb 09, 2024	BUY	$69.51 - $104.43 $28 Million - $42.1 Million	403,428 Added 187.01%	619,152 $61.6 Million
Q3 2023 Oct 27, 2023	BUY	$96.41 - $126.61 $4.6 Million - $6.04 Million	47,667 Added 28.36%	215,724 $22.3 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $36.7 Million - $49.7 Million	-309,310 Reduced 64.8%	168,057 $20.4 Million
Q1 2023 May 05, 2023	BUY	$135.66 - $197.02 $35.6 Million - $51.8 Million	262,782 Added 122.46%	477,367 $73.3 Million
Q4 2022 Feb 10, 2023	SELL	$118.38 - $210.04 $1.81 Million - $3.2 Million	-15,251 Reduced 6.64%	214,585 $38.5 Million
Q3 2022 Nov 01, 2022	BUY	$118.07 - $194.18 $258,927 - $425,836	2,193 Added 0.96%	229,836 $27.2 Million
Q2 2022 Aug 03, 2022	BUY	$117.13 - $176.59 $267,642 - $403,508	2,285 Added 1.01%	227,643 $32.5 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $23.6 Million - $43.9 Million	186,660 Added 482.35%	225,358 $38.8 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $8.68 Million - $14.2 Million	38,450 Added 15504.03%	38,698 $9.83 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $52,812 - $115,303	238 Added 2380.0%	248 $95,000
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $1,299 - $2,349	10 New	10 $2,000

Others Institutions Holding MRNA

# of Institutions

875

Shares Held

255M

Call Options Held

24M

Put Options Held

31.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account